![]()
25
| 4 | 2005
Klinisk Biokemi i Norden
Referencer
1. Down JL. Observations on the classification of
idiots. Lond Hosp Rep 1866;3:259-262 Reprinted
In Ment Retard 33; 54-56 (1995).
2. Patterson D, Costa AC. Downs syndrome and
genetics - a case of linked histories. Nat Rev Genet
2005;6(2):137-47.
3. Sundhedsstyrelsen. Fosterdiagnostik og risikovur-
dering. København: Sundhedsstyrelsen; 2003.
4. Nicolaides KH. Nuchal translucency and other
first-trimester sonographic markers of chro-
mosomal abnormalities. Am J Obstet Gynecol
2004;191(1):45-67.
5. Wald NJ, Rodeck C, Hackshaw AK, Walters J,
Chitty L, Mackinson AM. First and second trime-
ster antenatal screening for Down’s syndrome:
the results of the Serum, Urine and Ultrasound
Screening Study (SURUSS). Health Technol Assess
2003;7(11):1-77.
6. Wald NJ, George L, Smith D, Densem JW, Petterson
K. Serum screening for Down’s syndrome between
8 and 14 weeks of pregnancy. International
Prenatal Screening Research Group. Br J Obstet
Gynaecol 1996;103
(5)
:407-12.
7. Qin QP, Kokkala S, Lund J, Tamm N, Voipio-
Pulkki LM, Pettersson K. Molecular distinction of
circulating pregnancy-associated plasma protein
A in myocardial infarction and pregnancy. Clin
Chem 2005;51(1):75-83.
8. Spencer K, Cuckle HS. Screening for chromoso-
mal anomalies in the first trimester: does repe-
at maternal serum screening improve detection
rates? Prenat Diagn 2002;22(10):903-6.
9. Muller F, Doche C, Ngo S, Faina S, Charvin MA,
Rebiffe M, et al. Stability of free beta-subunit in
routine practice for trisomy 21 maternal serum
screening. Prenat Diagn 1999;19(1):85-6.
10. Spencer K. First trimester maternal serum
screening for Down’s syndrome: an evaluation
of the DPC Immulite 2000 free beta-hCG and
pregnancy-associated plasma protein-A assays.
Ann Clin Biochem 2005;42(Pt 1):30-40.
11. Laigaard J, Sorensen T, Frohlich C, Pedersen BN,
Christiansen M, Schiott K, et al. ADAM12: a novel
first-trimester maternal serum marker for Down
syndrome. Prenat Diagn 2003;23(13):1086-91.
12. Smith GC, Stenhouse EJ, Crossley JA, Aitken
DA, Cameron AD, Connor JM. Early-preg-
nancy origins of low birth weight. Nature
2002;417(6892):916.
plasma by high-performance liquid chromato-
graphy with tandem mass spectrometry. Rapid
Commun Mass Spectrom 2000;14:1835-1840.
21. Kuuranne T, Kurkela M, Thevis M, Schänzer
W, Finel M, Kostiainen R. Glucuronidation of
anabolic androgenic steroids by recombinant
human UDP-glucuronosyltransferases. Drug
Metab Dispos 2003:31;1117-1124
22. Taylor RL, Grebe SK, Singh RJ. Quantitative,
highly sensitive liquid chromatography- tan-
dem mass spectrometry method for detection of
synthetic corticosteroids, Clin Chem 2004; 50:
2345-2352
23. Frerichs VA, Tornatore KM. Determination of
the glucocorticoids prednisone, prednisolone,
dexamethasone, and cortisol in human serum
using liquid chromatography coupled to tan-
dem mass spectrometry, J Chromatogr B, 2004;
802:329-338
24. Lacey JM, Minutti CZ, Magera MJ, Taucher
AL, Casetta B, McCann M, Lymp J, Hahn,
SH, Rinaldo P, Matern D. Improved specificity
of newborn screening for congenital adrenal
hyperplasia by second-tier steroid profiling
using tandem mass spectrometry. Clin Chem
2004; 50; 621-625.
25. Fenske M. How much ”urinary free cortisol” is
really cortisol during water diuresis in healthy
individuals? Clin. Chem. 2004; 50:1102-1104
26. Wong T, Chackleton CH, Covey TR, Ellis G.
Identification of the steroids in neonatal plasma
that interfere with 17-alfa-hydroxyprogesterone
radioimmunoassays. Clin Chem 1992: 38: 1830-
1837.
27. Apter D, Jänne O, Karvonen P, Vihko R.
Simultaneous determination of five sex hor-
mones in human serum by radio-immunoassay
after chromatography on Lipidex-5000. Clin
Chem 1976: 22; 32-38.
28. Taieb J, Mathian B, Millot F, Patricot M-C,
Mathieu E, Queyrel N, Lacroix I, Somma-
Delpero C, Boudou P. Testosterone measured
by 10 immunoassay and by isotope-dilution
gas chromatography-mass spectrometry in sera
from 116 men, women and children. Clin Chem
2004; 49:1381-1395
(Fortsat fra side 13)
